Orgenesis Inc. Announces Acceptance of Technology by U.S. Patent Office MarketWatch (press release) The Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the risk of transplant rejection. If successful, this could mean the end of diabetes as we now know ... |
